The current study strongly suggests that WHpR is superior to BMI, WC, and WHtR in assessing the risk for T2D in humans with overweight and obesity as it more accurately reflects early decline of BCF in those without T2D as well as the decline of late phase insulin secretory capacity in individuals with T2D. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.